Zurueck zur Suche

Reporte zur Charge UT7347LA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

9Reporte angezeigt
0Todesfaelle
2Hospitalisiert
0Lebensbedrohlich
1Bleibende Schaeden
MA 2 ME 2 ND 1 IL 1

VAERS 1851126

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7347LA

schwer
Staat
MA
Alter
6,0
Geschlecht
M
Eingang
08.11.2021
Impfdatum
06.11.2021
Beginn
06.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Crying Inappropriate schedule of product administration Nervousness Seizure

Symptomtext

patient was here with both parents on 11/6/21 around 4:15pm to get both the pfizer covid and flu vaccines. pt had stated he felt a sting after getting the covid vaccine but after getting the flu vaccine, per vaccinating technician, he seemed like he was seizing. i had advised technician to lay him on his side just in case vomiting was to occur but he had come to moments later. when he came to, he immediately hung onto mom and was crying but when asked if he was nervous, he stated he was. i had instructed a technician to call for EMS and they had inspected him upon arrival. they had given them the option to either go to the hospital or go home and monitor for abnormal signs. parents had opted to go home

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
none reported
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1785759

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7347LA

schwer
Staat
ND
Alter
8,0
Geschlecht
F
Eingang
14.10.2021
Impfdatum
14.10.2021
Beginn
14.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Contusion Immediate post-injection reaction Loss of consciousness Mass Scratch Seizure Syncope

Symptomtext

Pt fainted about 1-2 minutes after receiving the vaccine, after patient was on the ground patient began having a seizure that last roughly 45 seconds to 1 minute. Pt came to and was evaluated by MD. vitals taken and were WNL, there was some bruising and scratches to R elbow as well as a lump to r back of head. Pt was re evaluated by physician before being medically cleared to go home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Multivitamin Vitamin C
Allergien
NKA
Vorherige Impfungen
-

VAERS 2147418

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7347LA

moderat
Staat
-
Alter
-
Geschlecht
F
Eingang
27.02.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein
Mobility decreased

Symptomtext

was bed ridden for 2 days afterwards; Initial information received on 14-Feb-2022 regarding an unsolicited valid serious case received from a consumer/non-hcp (non health care professional). This case involves an unknown age female patient who was bed ridden for 2 days afterwards, after receiving vaccine Influenza Quadrival A-B Vaccine [Fluzone Quadrivalent]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect Influenza Quadrival A-B Vaccine Suspension for injection with lot UT7347LA at an unknown dose via unknown route in unknown administration site as prophylactic vaccination. On an unknown date, the patient was bedridden (unknown latency) for 2 day afterwards (bedridden ), so she was concerned, she may had received high dose. This event was leading to disability. Action taken was not applicable for the event It was not reported if the patient received a corrective treatment for the event (Bedridden). At time of reporting, the outcome was Unknown for the event bedridden.; Sender's Comments: Sanofi company comment date 21-Feb-2022:This case concerns a female patient of unknown age who was bedridden for 2 days afterwards, after vaccination with Influenza Quadrival A-B Vaccine [Fluzone Quadrivalent]. A significant temporal relationship cannot be established due to lack of information on event onset date and product start date and hence, causal role of suspect product cannot be excluded in occurrence of the event. Further information regarding patient age, concurrent condition during vaccination, previous vaccination, concomitant medication and tolerance, allergic history, laboratory investigations excluding alternative etiologies for the reported event are needed to fully assess this case. Based upon the reported information, the role of the suspected influenza vaccine cannot be excluded in occurrence of the events and role of the individual suspect vaccine cannot be assessed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2128215

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE) · Charge UT7347LA

moderat
Staat
IL
Alter
-
Geschlecht
F
Eingang
19.02.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered Mobility decreased

Symptomtext

was bed ridden for 2 days afterwards; may have received the high-dose; Initial information received from on 14-Feb-2022 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case involves an adult female patient who was bed ridden for 2 days afterwards and may have received the high-dose, after receiving vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (strength, dose, formulation: unknown) with lot UT7347LA via unknown route in unknown administration site as prophylactic vaccination. It was reported that patient was bed ridden for 2 days afterwards, so she was concerned she may have received the high-dose ((extra dose administered). Patient was asking whether the lot of UT7347LA a FLUZONE was, or FLUZONE HIGH-DOSE VACCINE. Caller reported her clinic stated they administered FLUZONE VACCINE. Advised caller to contact clinic to gather NDC. Marked as potential to submit to Quality team to see if they were able to look up that information. Caller was frustrated that she could not locate the product via the lot number only, therefore, caller disconnected and said she had call back another time. Action taken with INFLUENZA VACCINE TRIVALENT (FLUZONE HIGH DOSE) was not applicable. It was not reported if the patient received a corrective treatment for the events At time of reporting, the outcome was Unknown for the events This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2218176

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7347LA

mild
Staat
-
Alter
63,0
Geschlecht
F
Eingang
06.04.2022
Impfdatum
06.12.2021
Beginn
07.12.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Abdominal pain lower Fungal infection Hydronephrosis Renal colic Stent placement

Symptomtext

ED to hospital admission on 1/2 for lower abdominal pain. Acute left renal colic, caused by the above + yeast encrusted left lower pole stent/ left upper and lower pole hydronephrosis, improved post urology intervention, stent replaced, cleared by urology to dc. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain lower
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1772102

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge ut7347la

mild
Staat
MA
Alter
26,0
Geschlecht
F
Eingang
08.10.2021
Impfdatum
06.10.2021
Beginn
07.10.2021
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Lymphadenopathy Pain

Symptomtext

Patient experienced slight pain and some swelling in her lymph nodes the day after her flu vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none listed
Vorgeschichte
none listed
Andere Medikamente
did not specify
Allergien
none
Vorherige Impfungen
-

VAERS 2369198

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7347LA

gering
Staat
ME
Alter
5,0
Geschlecht
F
Eingang
14.07.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Patient received a sub-optimal COVID-19 vaccine due to a storage and handling error. Vaccine was stored in a regular freezer prior to being refrigerated and then administered. The regulatory authority requested that a VAERS form be submitted for this patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2369187

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge ut7347la

gering
Staat
ME
Alter
6,0
Geschlecht
M
Eingang
14.07.2022
Impfdatum
18.04.2022
Beginn
18.04.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Patient received a sub-optimal COVID-19 vaccine due to a storage and handling error. Vaccine was stored in a regular freezer prior to being refrigerated and then administered. The CDC requested that a VAERS form be submitted for this patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2131136

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7347LA

gering
Staat
-
Alter
57,0
Geschlecht
M
Eingang
22.02.2022
Impfdatum
12.11.2021
Beginn
09.12.2021
Tage bis Beginn
27,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Anticoagulant therapy Cardiopulmonary bypass Coronary artery bypass

Symptomtext

Coronary artery bypass grafting x3 - left internal mammary artery grafted to LAD and reverse saphenous vein grafts placed to diagonal and right posterior descending coronary arteries on cardiopulmonary bypass. The patient was discharged on ASA, statin and beta blocker therapy. Plavix was added by CT surgery post-op and should be continued for one year (smaller targets). ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anticoagulant therapy
Hospital-Tage
11,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-